InvestorsHub Logo
Followers 3
Posts 1199
Boards Moderated 0
Alias Born 01/19/2010

Re: ventrikel post# 3983

Thursday, 05/13/2010 6:37:19 AM

Thursday, May 13, 2010 6:37:19 AM

Post# of 19508
Covidien to Present at Bank_of_America Merrill_Lynch Conference

Here is more information on what ventrikel posted about. It may be beneficial in listening as they may say something about Positron, and if they do I think we would like to know about it at the same time the market hears it. I am not trying to imply they will, but some on here believe they may be the company to be annouced soon.

http://investor.covidien.com/phoenix.zhtml?c=207592&p=irol-newsArticle&id=1424001

Covidien to Present at Bank of America Merrill Lynch Conference

MANSFIELD, Mass., May 07, 2010 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products, will present at the Bank of America Merrill Lynch 2010 Health Care Conference in New York on Thursday, May 13, 2010. José (Joe) Almeida, President, Medical Devices, will represent the company in a session scheduled at 8:00 a.m. ET.

A live audio webcast of the presentation can be accessed at Covidien's Investor Relations website: http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Finvestor.covidien.com&esheet=6280534&lan=en_US&anchor=http%3A%2F%2Finvestor.covidien.com&index=1&md5=354e9a4f99b97175e8dcd38439b27572. An archived edition of the presentation will be available following the live webcast.

ABOUT COVIDIEN

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2009 revenue of $10.7 billion, Covidien has 42,000 employees worldwide in more than 60 countries, and its products are sold in over 140 countries. Please visit http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.covidien.com&esheet=6280534&lan=en_US&anchor=www.covidien.com&index=2&md5=2df39d284b6be13a335ab0f83c6f27f3 to learn more about our business.


SOURCE: Covidien

Covidien
Eric Kraus, 508-261-8305
Senior Vice President
Corporate Communications
eric.kraus@covidien.com
or
Coleman Lannum, CFA, 508-452-4343
Vice President
Investor Relations
cole.lannum@covidien.com
or
Bruce Farmer, 508-452-4372
Vice President
Public Relations
bruce.farmer@covidien.com
or
Brian Nameth, 508-452-4363
Director
Investor Relations
brian.nameth@covidien.com